Kodi 7Oct 2012_6thABDC-Reduced

7/25/2019 Kodi 7Oct 2012_6thABDC-Reduced

1/59

Commercializing Innovation in Biotechnology

UPDATES ON THEBIOTECHNOLOGY INDUSTRY

IN MALAYSIA

7 October 2012


2/59

INVEST IN MALAYSIA

SupportiveGovernment

Policies andIncentives

Market Access,

Intellectual

Property andRegulatorySystem

Developed &Integrated

Infrastructure

Human Capital:

Highlymotivated,

educated andmulti-lingual

Quality of Life


3/59

ACCESS TO4 BILLIONPOPUL ATION INNEIGHBOURING REGIONS

. .wi thin 6 hours of f l ight

Centrally located in one of the most economically vibrant

regions in the world, Malaysia is perfectly positioned forinvestments with a rapidly developing ecosystem ready for

innovation, biotech and business.


4/59

14th most competitiveeconomy (of 59 countr

ies)IMD Wor

ld Compe

ti

tiveness

Scoreboard

5th in World CompetitiveR anking in East AsiaIMD Wor

ld Compe

ti

tive Ranking

s

Ranked 8th worldwide forEase of Doing Business inEast Asia and 4th forProtection of InvestorsDoing Business Repor

t 2011,World Bank


5/59

Ranked 4th worldwide forEnterprise Support of itsbiotech industryWorldview Scorecard 2011,Scientific American

2nd in ASEAN for richnessand promotion of innovationGlobal Innovation Index 2011,INSEAD

9th friendliest country inthe world

Forbes Ranking 2011


6/59

One Stop CentreFacilitation

Domestic DirectInvestment

Foreign DirectInvestment

Advocacy

BIOTECHCORP: ACCELERATING GROWTH OMALAYSIAS BIOECONOMY

BiotechCorpis the lead

development agency

for the biotechindustry in Malaysia.

Acts as a centralcontact point

providing support,

facilitation andadvisory services for

biotech and lifescience companies in

Malaysia.


7/59

ORGANISATION STRUCTURE: BIOTECHCOR

International Advisory Panel

Implementation Council

Ministry of ScienceTechnology & Innovation

Chairman Board of Directors

Dato Dr Mohd Nazlee Kamal CEO

Honorable Prime Minister of Malaysia YAB Dato Seri Najib Tun Razak

Ministry of Finance

Federal LandsCommissioner (JKPTG)


8/59

Malaysian InvestmentDevelopment

Authority

BiotechCorp works with Government Ministries, entities and

agencies to package attractive deals for global companies to invest

in Malaysian biotech industries.


9/59

NATIONALBIOTECHNOLOGY

POLICY


10/59

FOCUS AREAS AGRICULTURE HEALTHCARE

INDUSTRIAL


11/59

Investment RM 6 billion

Employment 40,000

Contributionto GDP

2.5%


Employment 80,000

Contributionto GDP

4.0%


Employment 160,000

Contributionto GDP

5.0%

Phase III Global Business

2016-2020

Phase II Science to Business

2011-2015

Phase I Capacity Building

2006-2010

NATIONAL BIOTECHNOLOGY POLICY


12/59

The BIOTECH sector

now represents

RM5.4 billion* in total

investments,

RM13.5 billion* in

revenues, 54,776 jobs

and 2.2% contribution to

overall GDP of Malaysia.

* USD1=RM3.16


13/59

NCER : NORTHERN CORRIDOR

ECONOMIC REGION

ECER : EAST COAST

ECONOMIC REGION

SCORE: SARAWAK

CORRIDOR OF

RENEWABLE

ENERGY

IRDA : ISKANDAR

REGION

SDC : SABAHDEVELOPMENT

CORRIDOR

Kerteh Bio-PolymerPark

BioXCell

Mukah

POIC Sandakan

Tawau

ESTABLISHED ECOSYSTEM OF BIOPARKS ANECONOMIC CORRIDORS

WILAYAHPERSEKUTUAN

LABUAN

SABAH

SARAWAK

TERENGGANU

JOHOR

KEDAH

PERLIS

P.PINANG

PERAK

SELANGOR

N.SEMBILANMELAKA

PAHANG

KELANTAN

WILAYAHPERSEKUTUANK.LUMPUR


14/59

ESTABLISHING ASIAS NEWBIOTECH ECOSYSTEM IN MALA


15/59

FDI AS KEY COMPONENT OFMALAYSIAN BIOTECHINDUSTRIAL GROWTH


16/59

First commercial bio-isobutanol plant in Asia

To build a commercial bio-based facility in Bio-Xcell

Major Biotechnology Investments inIndustrial Biotechnology

To develop Asias largestbiorefinery complex in KertehBiopolymer Park, Terengganu


17/59

Worlds first bio-methionineplant

Collaboration to build abioethanol demonstration

plant by converting empty fruit

bunches

Major Biotechnology Investments inIndustrial Biotechnology

The first plant in the world thatproduces PDO (1,3 Propanediol)

from crude glycerin


18/59

Major Biotechnology Investment in Agriculture Biotechnology

To establish a RegionalManagement Centre and an

Aquaculture Hub in Malaysia


19/59

Major Biotechnology Investment inHealthcare Biotechnology

Indias first billion -dollarbiotechnology company and

one of the biggestbiotechnology companies in

Asia


20/59

Packaged with a set ofcompetitive fiscal incentives

for both foreign as well asdomestic investors.

Supported by BiotechCorpsother initiatives in building

conducive enablingenvironment, the BioNexusProgram is now a credible

representation of Malaysiasemerging biotechnology

sector.

BIONEXUS STATUS COMPANIES: A VIBRANT, EMERGING COMMUNITY


21/59

Join a vibrant community of217 other BioNexus

companies representinginvestments from Malaysiaas well as from around the

world including the US,Europe, India, Taiwan, SouthKorea and Australia.

BioNexus companiestogether generate more than

RM2 billion in investments,RM721 million in revenue,

2,824 jobs, 21 patentsgranted and another 145

filed.

BIONEXUS STATUS COMPANIES: A VIBRANT, EMERGING COMMUNITY

Number of BNX companies(as at June 2012)

217 99

74

44 A g r i c u l t u r e

H e a l t h c a r e

I n d u s t r i a l


22/59

BioNexus Companies Listed on Stock Exchange

Marketcapitalisation:RM 645.6 million




Total Market capitalisation

RM 821.6 million


Note: Market capitalisation value as at 17 October 2011
http://www.londonstockexchange.com/home/homepage.htmhttp://www.purecircle.com/http://www.holistabio.com/


23/59

BioNexus Status companiesenjoy a set of incentives and

privileges contained withinthe BioNexus Bill ofGuarantees.


24/59

DEVELOPING WINNING PARTNERSHIP MODBETWEEN INDUSTRY AND UNIVERSITY

The 8 th Bill of Guarantee ensures commitmentto provide access and availability of

Physical Infrastructure,Shared Facilities & Services

BIONEXUS PARTNERS (BNP) PROGRAMME


25/59

KBioCor p

Region Northern Eastern Central Southern Sabah &Sarawak

Total

No. of BNP Labs/ Units 10 8 28 6 4 56

93% utilisation by industryplayers including BioNexus

companies in 2011

0.6 million revenue generated in2011

> 200 services / projectscollaboration / commercialisation

since 2009 till 2011

> 200 services offered inagricultural, healthcare &industrial biotechnology

3 BNP Centre of ExcellenceNatural Product Development (FRIM)

Industrial Product Development (UTM)Pharmacogenomics Research (UiTM)

56 BNP labs / units from 13 IHLs,3 RIs & 2 GCs

> 100 well maintainedhigh-end research facilities and

equipment handled byexperienced personnel

4.55 over 5 average rating of thecustomer satisfaction in 2011

BIONEXUS PARTNERS (BNP) PROGRAMMEEnhancing Public Private Partnership (PPP)

h l l f


26/59

Nanotechnology: High level nanotechnology applications fornon- cancer areas, including medicine,agriculture, nanomaterial and energyproduction

Exclusive global license

NanoBiotechnology Research & InnovationCentre (NanoBRI) in INFORMM, which is alsocapable of manufacturing custom-madenanoparticles

Opportunities:Collaborative R&D&C projects andcontract manufacturing

DotScan antibody microarray diagnostic: Development of diagnostic applications forvarious diseases e.g. solid tumors,haematological diseases, infectious diseaseand autoimmune diseases

Exclusive Malaysia & Singaporelicense

Institute of Medical Research (IMR) andUniversiti Putra Malaysia (UPM) to developnew applications from research projects

Opportunities :Collaborative R&D projects

Custodian: Custodian:

Licensor:Nanobiotix S.A.

Licensor:MedSaic Pty Ltd

Technology Platforms

T h l Pl f
http://www.google.com.my/imgres?imgurl=http://hamiac.com/en/images/stories/logo/UPM.jpg&imgrefurl=http://hamiac.com/en/index.php?option=com_content&view=article&id=95&Itemid=114&usg=__GSuYDBr7DApJIQaO3Gn82Qlty70=&h=273&w=248&sz=61&hl=en&start=1&zoom=1&itbs=1&tbnid=MFVM33ZG6-vgJM:&tbnh=113&tbnw=103&prev=/images?q=UPM&hl=en&gbv=2&tbm=isch&ei=IIelTdTVDovsuAP1yJ3vCAhttp://medsaic.com/index.html


27/59

Technology Platforms

Exclusive ASEAN license Unrestricted and perpetual rightto use

Licensor:FeyeCon Development &Implementation B.V

Licensor:

Supercritical Fluid Extraction (SFE) & ParticleFormation: Extraction and fractionation of nutraceuticaland bioactive compounds from naturalsources using CO2 technology

Marker Assisted Selection (MAS): Applications in plant and livestock breeding;Speed and efficacy of breeding programmesis enhanced through utilisation of geneticmarkers

A commercial scale Supercritical FluidExtraction Centre (SFC) is being established

Custodian: Custodian:

Centre for Marker Discovery and Validation(CMDV) established to provide commercialservices

Opportunities:Collaborative R&D&C projects , contract

research and contract manufacturing

Opportunities:Collaborative and contract research

DNA LandMarks Inc
http://images.google.com.my/imgres?imgurl=http://www.edaran.com/images/logo/sidic_mardi.gif&imgrefurl=http://www.edaran.com/sidic_client.php&usg=__AG0WSwHp8jhhyaXwaxxNILKlPIY=&h=370&w=376&sz=26&hl=en&start=2&tbnid=IicJGg0GqgGNOM:&tbnh=120&tbnw=122&prev=/images?q=mardi+logo&gbv=2&hl=en&sa=Ghttp://www.google.com.my/imgres?imgurl=http://hamiac.com/en/images/stories/logo/UPM.jpg&imgrefurl=http://hamiac.com/en/index.php?option=com_content&view=article&id=95&Itemid=114&usg=__GSuYDBr7DApJIQaO3Gn82Qlty70=&h=273&w=248&sz=61&hl=en&start=1&zoom=1&itbs=1&tbnid=MFVM33ZG6-vgJM:&tbnh=113&tbnw=103&prev=/images?q=UPM&hl=en&gbv=2&tbm=isch&ei=IIelTdTVDovsuAP1yJ3vCA


28/59

Potential Market Access

Malaysia is one of the only countries in the regionwith PIC Scheme membership

Members of PIC/S includes USA, EU countriesCanada and Australia

PIC/S MemberCountries

Trade Preferential System- Organisation of IslamicCountries (TPS-OIC) under negotiation

Malaysia as a Halal Hub Malaysias standing as a moderate, Islamic country

Middle EasternCountries

Comprehensive Economic Cooperation Agreement(CECA) with INDIA

ASEAN Countries Regulatory Harmonization andfuture Mutual Recognition

EmergingMarkets


29/59

Regulatory Framework

Drug Control Authority under MOH All drugs regulated by the National

Pharmaceutical Control Bureau

PrincipalRegulatory Authority

All commercial life sciences relatedactivities requires compliance to GMP &GLP Standards

Membership to PIC/S since 2002

GMP & GLPStandards

Guidelines for Registration of Biosimilars,regulated by MOH 2008Biosimilars

Stem Cell Guidelines, regulated by MOH.Stem Cells


30/59

MALAYSIA TOWARDS BUILDING A


31/59

MALAYSIA TOWARDS BUILDING AWORLD CLASS IP INFRASTRUCTUR

Specialised IP Courts

Malaysia is one of the first few countries in the region

to introduce specialised IP Courts.The IP Courts have successfully reduced the time taken toresolve an IP dispute matter from 4 -6 years to 12-14 months.


32/59

MALAYSIA TOWARDS BUILDING AWORLD CLASS IP INFRASTRUCTURE

IP PendencyPatent pendency timeframe

down from 43 months in 2007to 26 months in 2011.

IP ProtectionRanked #31 out of 142countries in IP Protection(IMD Global Competitiveness Report2011-2012)

MALAYSIA TOWARDS BUILDING A


33/59

IP Valuation

Initiatives are currently being co-ordinated by theMalaysian Government & MyIPO to create a frameworkto enable financial institutions to recognise IP as partof the company assets & also to enable IP to be used ascollateral.

MALAYSIA TOWARDS BUILDING AWORLD CLASS IP INFRASTRUCTUR


34/59

STRATEGICINITIATIVES

WITHINTERNATIONA

PARTNERS


35/59

CLIB2021 SOUTH EAST ASIA OFFIHOSTED BY BIOTECHCORP INKUALA LUMPUR, MALAYSIA

CLIB2021 is an association of>70 companies companies,academic institutes andinvestors based in Europe,fostering research and jointcollaborations in industrialbiotechnology.


36/59

POSITIONING MALAYSIA TO BECO A STRONG RESEARCH FORCE

IN THE REGION

BiotechCorps strategic collaboration with Singapores Quintiles East Asia PteLtd in the areas of Shared Services Central

Laboratory and Biobank, Clinical ResearchTraining Program, Stem Cell Research andNational Vaccine Hub.


37/59

Providing specialised technical trainingin bioprocess to Malaysian graduates.

3 of the 8 program graduates arecurrently furthering their studies inKorea.

TALENT DEVELOPMENT PROGRAWITH KOREAN RESEARCH INSTIT

OF BIOSCIENCE & BIOTECNOLOG(KRIBB)


38/59

STELLAR COLLABORATION WITHSTRONG GOVERNMENT COMMITM

To enhance scientific talentof Malaysian researchers.

Next in pipeline: CreatingQB3 satellite program inMalaysia within a hub ofbioclusters.

Neopeutics - The first commercialenterprise to emerge from QB3-

Malaysia Program.
http://www.neopeutics.com/http://malaysia.qb3.org/index.html


39/59

THE PILLARS TOWARD VISION 2020

HIGH IMPACT INITIATIVES

1 Malaysia

People First,Performance Now

GovernmentTransformationProgramme

6 National KeyResult Areas

EconomicTransformationProgramme

8 Strategic ReformInitiatives

10th MalaysiaPlan

MacroeconomicGrowth Target &Expenditure Allocation

VISION2020

H I G H I M PA C T I N I T I AT I V E S

TOWARDS ACHIEVING HIGH


40/59

TOWARDS ACHIEVING HIGHPER CAPITA INCOME IN 2020

Current GNIper capita

(2009 1)RM23,700 or

USD6,700

Real growth rate of 6% p.a.over next 10 years

Projected GNI

per capita(2020 2)RM48,000 orUSD15,000

MIDDLE INCOME NATION

HIGH INCOME NATION12009 population 27.9 million, 2020 projected population31.6 million (EPU projection)2 At 2020 prices, consistent with EPU assumptions forinflation~2.8% and population growth~1%

Source : World Bank, EPU


41/59

NATIONAL

BIOMASSSTRATEGY


42/59

COP 15COMMITMENT


43/59

Leveraging on strengths inexisting industries. .

petrochemical oil palmpetrochemical oil palm


44/59

Current PetrochemicalFeedstock

C1: Kemaman

C2, C3, C4:Kertih

C2, C3:Gebeng

C2, C3, C4, C5:RAPID


45/59

Malaysia is located ontropical belt

BIOMASS 5X HIGHER


46/59

Close to major markets

Stable economic position

High productivity of biomass

Existing plantation infrastructure

Innovation-driven transition to highincome economies

1

2

3

45

Malaysia Has A Strong Positioningto LEAD the Industry


47/59

Biomass isour new

wellhead


48/59

Microbes &

Enzymes areour newcracker


49/59

Carbohydrates

productionplant is our newrefinery


50/59

Biochemicalsare our new

petrochemicals

All these initiati es became an


51/59

BIOECONOMY

INITIATIVEMALAYSIA

All these initiatives became anecosystem for

A GROWING STRATEGIC INTEREST IN BIOECONO


52/59

US$ 318.8mil (2008)^

US$46.5bn(2007*)

US$126.6bn(2010)*

US$2.6 trillion(2009)*

Bioeconomy to contribute a global average of 2.7% to GDP by 2030 OECD estimates

US$86.5 bn(2010)*

US$ 3.6bn(2008)*

US$ 4.3bn(2010)*

* Recorded figure^ Forecast figure

Announced:2009

Announced:April 2012

Announced:Sept 2010

Announced:June 2007

Announced:Nov. 2008

Announced:2008

US$18.9bn(2012)^

Announced:June 2012

US$18.8bn(2012)^

Announced:June 2012

EstablishedBioeconomies

Newly AnnouncedBioeconomies

A GROWING STRATEGIC INTEREST IN BIOECONO ACROSS THE GLOBE

To make bioeconomy work for
http://en.wikipedia.org/wiki/File:Flag_of_Finland.svg


53/59

YABDATO SRI MOHD NAJIB TUN HAJI ABDUL RAZAKPRIME MINISTER OF MALAYSIA

To make bioeconomy work for

Malaysia, we need to relook at how

best to deploy our resources,

enhance private-public

partnerships, build strengths in

focus areas, specialize and enhance

service levels..

SUPPORTING GOVERNMENT COMMITMENT


54/59

SUPPORTING GOVERNMENT COMMITMENTDELIVER ECONOMIC AND SOCIAL BENEFI

GNIHuman Capital

Investment

10 EPPS / 20 TRIGGER PROJECTS OF T


55/59

3 trigger projects

Industrial bioInputs Biochemicals Biomaterials

1 2 3

3 trigger projects 4 trigger projects

Bio-based farminputs

High valuebioingredients

High value foodvarieties

4 5 6

2 trigger projects 2 trigger projects 2 trigger projects

Industrialbiotech

Agriculturebiotech

Biosimilars Drug discovery Molecularscreening

7 8 9 Stem cells andregenerative

medicine

10

1 trigger project 1 trigger project 1 trigger project 1 trigger project

Healthcarebiotech

10 EPPS / 20 TRIGGER PROJECTS OF TBIOECONOMY INITIATIVE MALAYS

COMMITTED INVESTMENTS FOR TRIGGER PROJE


56/59

NIBM

GNIRM3.6bn

InvestmentRM10bn

Employment16,300

WILL BE CARRIED OUT ACROSSPENINSULAR MAL AYSIA, SABAH AND SARAW


57/59

DISCOVER MALAYSIA YOUR UNIQUE BIOTECHNOLOGYINVESTMENT DESTINA TION


58/59

B I O M A L AY S I A 2 0 1 2CONFERENCE & EXHIBITION

5 - 7 N O V E M B E R 2 0 1 2K U A L A L U M P U R

See you at


59/59

Thank You

Kodi Isparan Kandasamy, PhDSenior Vice President (Agriculture)[email protected]
mailto:[email protected]:[email protected]

Kodi 7Oct 2012_6thABDC-Reduced

Documents

Transcript of Kodi 7Oct 2012_6thABDC-Reduced